mFLUSVIA (mRNA-1010) 2026-2027 SYRINGES

MFLUSIVA (Influenza Vaccine, mRNA) injectable suspension, for
intramuscular use approved for use in ages 50 and older
2026-2027 Formula

NOW AVAILABLE TO ORDER

Contract pricing is subject to adjustment based on changes to Moderna’s Wholesale Acquisition Cost (WAC)

Orders are being accepted and will be released as product becomes available from the manufacturer.

Immediate shipment is not guaranteed and fulfillment is subject to manufacturer availability.

Medico-Mart, Inc. is not liable for any manufacturer delays or supply shortages.

Returnability percentages are determined by your PBG/GPO's contract with Moderna.